- STRAD-BINDING AGENTS AND USES THEREOF
-
Disclosed herein, inter alia, are compounds for binding STRAD pseudokinase and uses thereof.
- -
-
Paragraph 1332-1334
(2021/08/06)
-
- BET INHIBITORS FOR MODULATING DUX4 EXPRESSION IN FSHD
-
The present disclosure provides BET inhibitors of the formula: wherein the variables are defined herein, as well as pharmaceutical compositions thereof. The present disclosure also provides methods of treating a patient comprising administering a bromo- and extra-terminal (BET) domain inhibitor for the treatment of FSHD which modulates DUX4 expression. In some embodiments, the present methods comprise using one or more BET inhibitors as a therapeutic agent for the treatment of FSHD patients including patients who are being treated with one or more palliative treatments such as therapy and/or agents which lead to increased muscle mass.
- -
-
Page/Page column 268; 269
(2020/07/14)
-
- GLUCOSE UPTAKE INHIBITORS
-
this invention provides compounds that modulate glucose uptake activity and cellular transport/uptake of glucose, and particularly GLUTS3, but also including but not limited to GLUT1-14 (SLC2A1-SLC2A14). Compounds of the invention are useful for treating diseases, including cancer, autoimmune diseases and inflammation, infectious diseases, and metabolic diseases.
- -
-
Paragraph 0172; 0175-0177
(2020/01/24)
-
- NOVEL MACROCYCLIC DERIVATIVES, PROCESS FOR PREPARING SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
-
Compound of formula (I): wherein A1, A2, Ra, Rb, Rc, Rd, R3, R4, X, Y and G are as defined in the description, and their use in the manufacture of medicaments.
- -
-
Paragraph 0120-0122
(2020/08/25)
-